Baxter International Inc. (BAX)

Market Cap	16.90B
Revenue (ttm)	10.64B
Net Income (ttm)	-649.00M
Shares Out	511.62M
EPS (ttm)	-1.27
PE Ratio	n/a
Forward PE	13.32
Dividend	$0.68 (2.05%)
Ex-Dividend Date	Feb 28, 2025

Volume	890,496
Open	33.76
Previous Close	33.60
Day's Range	33.01 - 33.85
52-Week Range	28.34 - 43.99
Beta	0.60
Analysts	Buy
Price Target	38.56 (+16.71%)
Earnings Date	May 1, 2025

About BAX

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; administrative sets; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technolog...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1931
• Employees: 60,000
• Stock Exchange: NYSE
• Ticker Symbol: BAX
• Website: https://www.baxter.com

Analyst Forecast

According to 9 analysts, the average rating for BAX stock is "Buy." The 12-month stock price forecast is $38.56, which is an increase of 16.71% from the latest price.

Price Target

$38.56

(16.71% upside)

Analyst Consensus: Buy